Results 11 to 20 of about 502,506 (259)

Importance of Hypervariable Region 2 for Stability and Affinity of a Shark Single-Domain Antibody Specific for Ebola Virus Nucleoprotein. [PDF]

open access: yesPLoS ONE, 2016
Single-domain antibodies derived from the unique New Antigen Receptor found in sharks have numerous potential applications, ranging from diagnostic reagents to therapeutics.
George P Anderson   +7 more
doaj   +1 more source

Single-chain Fragment variable antibody targeting cholecystokinin-B receptor for pain reduction

open access: yesNeurobiology of Pain, 2021
The cholecystokinin B receptor and its neuropeptide ligand are upregulated in chronic neuropathic pain models. Single-chain Fragment variable antibodies were generated as preferred non-opioid targeting therapy blocking the cholecystokinin B receptor to ...
K.N. Westlund   +7 more
doaj   +1 more source

Shelf-Life Extension of Fc-Fused Single Chain Fragment Variable Antibodies by Lyophilization

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
Generation of sequence defined antibodies from universal libraries by phage display has been established over the past three decades as a robust method to cope with the increasing market demand in therapy, diagnostics and research.
Kai-Thomas Schneider   +13 more
doaj   +1 more source

Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase

open access: yesMolecules, 2021
Proviral integration site of Moloney virus-2 (PIM2) is overexpressed in multiple human cancer cells and high level is related to poor prognosis; thus, PIM2 kinase is a rational target of anti-cancer therapeutics.
Kanasap Kaewchim   +6 more
doaj   +1 more source

Microbial approach of epitope tagged MFE-23 single fragment antibodies production

open access: yesJKKI (Jurnal Kedokteran dan Kesehatan Indonesia), 2020
Background: Antibodies have been investigated for future clinical application in cancer management. An antibody, MFE-23 scFv is known for its ability to bind Carcinoembryonic Antigen (CEA).
Razmaeda Sarastry
doaj   +1 more source

A multi-Fc-species system for recombinant antibody production

open access: yesBMC Biotechnology, 2009
Background Genomic, transcriptomic and proteomic projects often suffer from a lack of functional validation creating a strong demand for specific and versatile antibodies.
Nizak Clément   +6 more
doaj   +1 more source

Optimization of the crystallizability of a single-chain antibody fragment [PDF]

open access: yesActa Crystallographica Section F Structural Biology Communications, 2014
Single-chain variable antibody fragments (scFvs) are molecules with immense therapeutic and diagnostic potential. Knowledge of their three-dimensional structure is important for understanding their antigen-binding mode as well as for protein-engineering approaches such as antibody humanization.
Jana, Škerlová   +5 more
openaire   +2 more sources

Enhancement of the neutralization ability resulting from a single amino acid change in the light chain of a chimeric antibody against SARS-CoV-2

open access: yesShanghai Jiaotong Daxue xuebao. Yixue ban, 2023
Objective·To screen the human-mouse chimeric antibodies that neutralize the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and analyse the key amino acid site changes in their light chain.Methods·Antibody heavy chain gene-humanized mice ...
YIN Zi   +5 more
doaj   +1 more source

Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle

open access: yesNeurobiology of Disease, 1995
Vascular pathology is an underestimated complication of neurofibromatosis 1 (NF1). Manifestations include renovascular stenosis with associated hypertension, cerebrovascular occlusion, visceral ischaemia and aneurysms of smaller arteries.
Karen K. Norton   +2 more
doaj   +1 more source

The eIg technology to generate Ig-like bispecific antibodies

open access: yesmAbs, 2022
Bispecific antibodies have emerged as therapeutic molecules with a multitude of modes of action and applications. Here, we present a novel approach to solve the light-chain problem for the generation of bispecific Ig-like antibodies using the second ...
Lennart Kühl   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy